| 90429-2 |
Microorganism preliminary growth |
PrThr |
Body fld |
Pt |
Ord |
Aerobic culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Body fluid by Aerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90429-2 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Microorg prel grow Fld Ql Aerobe Cult |
|
|
|
|
|
Aerobe; Aerobe Cult; Aerobed; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9043-1 |
Class |
Type |
Urinary bladder irrigation tube |
Pt |
Nom |
|
|
ACTIVE |
Type of Bladder irrigation tube |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
IO.TUBE |
|
9043-1 |
|
|
|
|
|
|
|
|
0 |
Bladder irrigation tube Class |
|
|
|
|
|
IO.TUBE; Nominal; Point in time; Random; Tub; Tube, unspecified; Typ |
2.27 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90430-0 |
Microorganism preliminary growth |
PrThr |
Body fld |
Pt |
Ord |
Anaerobic culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Body fluid by Anaerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90430-0 |
|
Anaerobic culture |
|
|
Both |
|
|
|
0 |
Microorg prel grow Fld Ql Anaerobe Cult |
|
|
|
|
|
Anaero; Anaerobe; Anaerobe Cult; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90431-8 |
Microorganism preliminary growth |
PrThr |
Body fld |
Pt |
Ord |
Anaerobic culture+Antimicrobial neutralizer |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Body fluid by Anaerobic culture with antimicrobial neutralizer |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90431-8 |
|
Anaerobic culture+Antimicrobial neutralizer |
|
|
Both |
|
|
|
0 |
Microorg prel Fld Ql Anaer cult + neut |
|
|
|
|
|
Anaer cult+Abx neut; Anaero; Anaerobe; Anaerobe Cult; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90432-6 |
Microorganism preliminary growth |
PrThr |
Platelets^BPU |
Pt |
Ord |
Anaerobic culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Anaerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90432-6 |
|
Anaerobic culture |
|
|
Both |
|
|
|
0 |
Microorg prel Plts BPU Ql Anaer Cult |
|
|
|
|
|
Anaero; Anaerobe; Anaerobe Cult; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Platelet; Platelet adequacy; Platelet estimate; Plt; Plts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90433-4 |
Mycobacterium preliminary growth |
PrThr |
Sputum |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Mycobacterium preliminary growth [Presence] in Sputum by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90433-4 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Mycobact prelim grow Spt Ql Cult |
|
|
|
|
|
Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Lower respiratory; Lung; Microbiology; Myco; Mycobact; Mycobact prelim grow; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec; Spt; Sputum; Tuberculosis |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90434-2 |
Microorganism preliminary growth |
PrThr |
Platelets^BPU |
Pt |
Ord |
Aerobic culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Aerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90434-2 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Microorg prel Plts BPU Ql Aerob Cult |
|
|
|
|
|
Aerobe; Aerobe Cult; Aerobed; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Platelet; Platelet adequacy; Platelet estimate; Plt; Plts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90435-9 |
Microorganism preliminary growth |
PrThr |
Bld |
Pt |
Ord |
Aerobic culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Blood by Aerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90435-9 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Microorg prel grow Bld Ql Aerobe Cult |
|
|
|
|
|
Aerobe; Aerobe Cult; Aerobed; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90436-7 |
Microorganism preliminary growth |
PrThr |
Body fld |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Body fluid by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90436-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Microorg prel grow Fld Ql Cult |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90437-5 |
Microorganism preliminary growth |
PrThr |
Bld |
Pt |
Ord |
Anaerobic culture |
|
ACTIVE |
Microorganism preliminary growth [Presence] in Blood by Anaerobe culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90437-5 |
|
Anaerobic culture |
|
|
Both |
|
|
|
0 |
Microorg prel grow Bld Ql Anaerobe Cult |
|
|
|
|
|
Anaero; Anaerobe; Anaerobe Cult; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90438-3 |
Mycobacterium preliminary growth |
PrThr |
Tiss |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Mycobacterium preliminary growth [Presence] in Tissue by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90438-3 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Mycobact prelim grow Tiss Ql Cult |
|
|
|
|
|
Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Myco; Mycobact; Mycobact prelim grow; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified; Tuberculosis |
2.67 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90439-1 |
Atypical pneumonia pathogens panel |
- |
Respiratory System Specimen |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
Atypical pneumonia pathogens panel - Respiratory system specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
90439-1 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
Atypical PNA path Pnl Resp NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Atyp; Atypical PNA path Pnl; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Reactive; Respiratory; RS; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.75: SYSTEM: There are 2 similar system's in LOINC: 1- Respiratory system 2- Respiratory specimen Due to an applied logic, the display in the System axis for 1 is Respiratory (adjective) without specification of sample, specimen, or other specific noun, while 2 is displayed fully as Respiratory specimen. Therefore for now we replaced 1 with Respiratory system specimen, which will affect 83 term. The result is replacing "Respiratory" with "Respiratory system specimen". This is the short approach. The bigger project is to potentially merge data that has either 1 or 2 together. This is a project to pass by the laboratory committee and will involve about 1500 concepts.; |
0 |
| 9044-9 |
Urinary bladder irrigation tube site |
Anat |
*^Patient |
Pt |
Nom |
|
|
ACTIVE |
Urinary bladder irrigation tube site |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
IO.TUBE |
|
9044-9 |
|
|
|
|
|
|
|
|
0 |
Urinary bladder irrigation tube site |
|
|
|
|
|
Anatomy; IO.TUBE; Nominal; Point in time; Random |
2.27 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90440-9 |
BK virus+JC Virus DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90440-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
BKV+JCPyV DNA Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BKV; BKV+JCPyV; BKV+JCPyV DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90441-7 |
Bordetella pertussis & Bordetella parapertussis DNA panel |
- |
Nph |
Pt |
- |
|
|
ACTIVE |
Bordetella pertussis and Bordetella parapertussis DNA panel - Nasopharynx |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
90441-7 |
|
|
|
|
Order |
|
|
|
0 |
B pert+parapert DNA Pnl Nph |
|
|
|
|
|
B parapert; B parapertussis; B pert; B pert+parapert DNA Pnl; B pertussis; Deoxyribonucleic acid; ID; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Pan; PANEL.MICROBIOLOGY; Panl; Pertussis; Pnl; Point in time; Random; Whooping cough |
2.65 |
2.65 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 90442-5 |
Coxiella burnetii aroE gene |
PrThr |
Tiss |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90442-5 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
C burnet aroE Tiss Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnet aroE; C burnetii; Coxiella burnettii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90443-3 |
Coxiella burnetii aroE gene |
PrThr |
Ser/Plas/Bld |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Coxiella burnetii aroE gene [Presence] in Serum, Plasma or Blood by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90443-3 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
C burnet aroE SerPlBld Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C burnet; C burnet aroE; C burnetii; Coxiella burnettii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.73 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90444-1 |
Diethylpropion |
MCnc |
Ser/Plas/Bld |
Pt |
Qn |
Confirm |
|
ACTIVE |
Diethylpropion [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
90444-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Diethylpropion SerPlBld Cfm-mCnc |
|
|
|
|
|
Addiction; Amphepramone; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diethylprop; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Tenuate; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 90445-8 |
ePHEDrine |
MCnc |
Ser/Plas/Bld |
Pt |
Qn |
Confirm |
|
ACTIVE |
ePHEDrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
90445-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Ephedrin SerPlBld Cfm-mCnc |
|
|
|
|
|
Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ectasule; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 90446-6 |
Pseudoephedrine |
MCnc |
Ser/Plas/Bld |
Pt |
Qn |
Confirm |
|
ACTIVE |
Pseudoephedrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
90446-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Pseudoephedrine SerPlBld Cfm-mCnc |
|
|
|
|
|
Blood; Cenafed; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Sudafed; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 90447-4 |
Delafloxacin |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Delafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
90447-4 |
|
MIC |
|
|
Both |
|
|
|
0 |
DLX Islt MIC |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Baxdela; DLX; Fluoroquinolone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 90448-2 |
Coccidioides sp Ab.IgM |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
Index value |
|
|
|
|
|
|
MICRO |
|
90448-2 |
|
|
|
|
Both |
|
|
|
0 |
Coccidioides IgM SerPl-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Coccidiodes; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; Valley fever |
2.73 |
2.65 |
|
|
|
|
|
|
|
{Index_val} |
|
|
|
0 |
| 90449-0 |
Norovirus genogroup I & II RNA |
Prid |
XXX |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Norovirus genogroup I and II RNA [Identifier] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90449-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Norovirus GI + GII RNA Spec NAA+probe |
|
|
|
|
|
2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Norovirus 1; Norovirus G1; Norovirus GI; Norovirus GI + GII; Norovirus GI + GII RNA; Norovirus GI+II; Norwalk virus; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9045-6 |
Calcium intake |
Sub |
^Patient |
Pt |
Qn |
Estimated |
|
ACTIVE |
Calcium intake Estimated |
|
MIN |
DefinitionDescription |
|
|
mol |
|
|
|
|
|
|
IO_IN_SALTS+CALS |
|
9045-6 |
|
Estimated |
|
|
|
|
|
|
0 |
Calcium intake Est |
|
|
|
|
|
Ca; Cal; Est; estimation; IO_INTAKE_SALTS+CALORIES; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance amount |
2.48 |
1.0i |
|
|
|
|
|
|
|
mol |
|
|
|
0 |
| 90450-8 |
Herpes simplex virus DNA |
PrThr |
Asp |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Herpes simplex virus DNA [Presence] in Aspirate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
90450-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HSV DNA Aspirate Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
